Clinical trials: Sphenopalatine Neuralgia
Migraine in Children, Sphenopalatine Neuralgia
SPG Block for Acute Pediatric Migraine
This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2% lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10 years of age presenting to a pediatric…
- Conditions
- Migraine in Children, Sphenopalatine Neuralgia, Migraine in Adolescence
- Trial name
- NCT03984045
- Testing
- Lidocaine topical, Prochlorperazine Injection
- Where
- United States
- Volunteers
- 72 people
- Sponsor
- Newark Beth Israel Medical Center
Migraine in Children, Pain, Neuropathic
Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients
Single-center, open-label, pre-post treatment pilot study to evaluate the safety and effectiveness of sphenopalatine ganglia blocks for the treatment of chronic migraine in the pediatric population.
- Trial name
- NCT04466826
- Testing
- Headache Journal, Sphenopalatine Block, Tx360
- Where
- United States
- Sponsor
- Washington University School of Medicine